Public consultations on applications for authorisation
ECHA is looking for comments on 19 applications for authorisation covering 30 uses of:
- 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated; and
- 4-nonylphenol, branched and linear, ethoxylated.
The substances are used in the production of various medical devices (e.g. in vitro diagnostic kits and reagents) and medicinal, biopharmaceuticals and laboratory products (e.g. active pharmaceutical ingredients); also used in the manufacture of interlayer polymer films for laminated safety glass.
The deadline for comments is 8 January 2020.
More information are available on the current consultations page on ECHA's website.